(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide

C114H124N24O16S4 — CID 158950663

IUPAC(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide
SMILESCC(C)Nc1nc([C@@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CC(C)Nc1nc([C@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CCNc1nc([C@@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CCNc1nc([C@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1
InChIInChI=1S/2C29H32N6O4S.2C28H30N6O4S/c2*1-17(2)31-29-33-23(16-40-29)24-22-8-5-4-7-20(22)15-34(24)28(39)26(37)25(36)27(38)32-18(3)19-9-11-21(12-10-19)35-14-6-13-30-35;2*1-3-29-28-32-22(16-39-28)23-21-8-5-4-7-19(21)15-33(23)27(38)25(36)24(35)26(37)31-17(2)18-9-11-20(12-10-18)34-14-6-13-30-34/h2*4-14,16-18,24-26,36-37H,15H2,1-3H3,(H,31,33)(H,32,38);2*4-14,16-17,23-25,35-36H,3,15H2,1-2H3,(H,29,32)(H,31,37)/t18-,24+,25-,26-;18-,24-,25-,26-;17-,23+,24-,25-;17-,23-,24-,25-/m1111/s1
InChIKeyJLJOTPAXNRKZGW-HHWXUDPQSA-N
MW2214.67 g/mol
LogP11.94
Rot. Bonds36

About (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide

(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide (PubChem CID 158950663) has the molecular formula C114H124N24O16S4 and a molecular weight of 2214.67 g/mol. Its IUPAC name is (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide.

Molecular Properties

Compound Name(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide
PubChem CID158950663
Molecular FormulaC114H124N24O16S4
Molecular Weight2214.67 g/mol
Exact Mass2212.85
IUPAC Name(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide
SMILESCC(C)Nc1nc([C@@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CC(C)Nc1nc([C@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CCNc1nc([C@@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CCNc1nc([C@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1
InChIInChI=1S/2C29H32N6O4S.2C28H30N6O4S/c2*1-17(2)31-29-33-23(16-40-29)24-22-8-5-4-7-20(22)15-34(24)28(39)26(37)25(36)27(38)32-18(3)19-9-11-21(12-10-19)35-14-6-13-30-35;2*1-3-29-28-32-22(16-39-28)23-21-8-5-4-7-19(21)15-33(23)27(38)25(36)24(35)26(37)31-17(2)18-9-11-20(12-10-18)34-14-6-13-30-34/h2*4-14,16-18,24-26,36-37H,15H2,1-3H3,(H,31,33)(H,32,38);2*4-14,16-17,23-25,35-36H,3,15H2,1-2H3,(H,29,32)(H,31,37)/t18-,24+,25-,26-;18-,24-,25-,26-;17-,23+,24-,25-;17-,23-,24-,25-/m1111/s1
InChIKeyJLJOTPAXNRKZGW-HHWXUDPQSA-N
XLogP11.94
TPSA530.44 Ų
H-Bond Donors16
H-Bond Acceptors36
Rotatable Bonds36
Heavy Atoms158
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002214.67
LogP ≤ 511.94
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1036

Analyze (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide?
The IUPAC name of (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide (CID 158950663) is (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide.
What is the SMILES notation for (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide?
The canonical SMILES for (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide is CC(C)Nc1nc([C@@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CC(C)Nc1nc([C@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CCNc1nc([C@@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.CCNc1nc([C@H]2c3ccccc3CN2C(=O)[C@H](O)[C@@H](O)C(=O)N[C@H](C)c2ccc(-n3cccn3)cc2)cs1.
What is the InChIKey of (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide?
The InChIKey is JLJOTPAXNRKZGW-HHWXUDPQSA-N. The full InChI is InChI=1S/2C29H32N6O4S.2C28H30N6O4S/c2*1-17(2)31-29-33-23(16-40-29)24-22-8-5-4-7-20(22)15-34(24)28(39)26(37)25(36)27(38)32-18(3)19-9-11-21(12-10-19)35-14-6-13-30-35;2*1-3-29-28-32-22(16-39-28)23-21-8-5-4-7-19(21)15-33(23)27(38)25(36)24(35)26(37)31-17(2)18-9-11-20(12-10-18)34-14-6-13-30-34/h2*4-14,16-18,24-26,36-37H,15H2,1-3H3,(H,31,33)(H,32,38);2*4-14,16-17,23-25,35-36H,3,15H2,1-2H3,(H,29,32)(H,31,37)/t18-,24+,25-,26-;18-,24-,25-,26-;17-,23+,24-,25-;17-,23-,24-,25-/m1111/s1.
What are the key properties of (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide?
(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide has a molecular weight of 2214.67 g/mol, XLogP of 11.94, 36 rotatable bonds, 16 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R)-2,3-dihydroxy-4-oxo-4-[(1R)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-2,3-dihydroxy-4-oxo-4-[(1S)-1-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1R)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide;(2R,3R)-4-[(1S)-1-[2-(ethylamino)-1,3-thiazol-4-yl]-1,3-dihydroisoindol-2-yl]-2,3-dihydroxy-4-oxo-N-[(1R)-1-(4-pyrazol-1-ylphenyl)ethyl]butanamide is sourced from PubChem (CID 158950663), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).